Atlas Trials

Dose Escalation and Proof-of-Concept Studies of Vactosertib (TEW-7197) Monotherapy in Patients With MDS

Clinical trial NCT03074006 · COMPLETED

Trial details

NCT number
NCT03074006
Sponsor
MedPacto, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Myelodysplastic Syndromes
Start date
2018-01-04
Primary completion
2019-12-31
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.